Amazon and Other Quality Stocks Have Been Hit Hard. They Could Be Buys. 

Quality stocks have been out of favor for a while now. The category includes names that have been slammed but that have bright outlooks—and those are potential buys.  There are many ways to define a q...

Here are five companies to pick if Goldman Sachs is right about the stock market being flat in 2023

Hearts, flowers and CPI data. Get ready for Tuesday. And hell hath no fury like a disappointed Wall Street. The last time CPI let the markets down — last September — stocks melted down like chocolate....

JNJ Bought Up Biotech Stock MeiraGTx. It Sold Procept BioRobotics.

Johnson & Johnson recently increased an investment in an embattled biotech stock, and slashed a position in a maker of surgical robotics that rocketed last year. Johnson & Johnson (ticker: JNJ...

Why MGM Resorts International Stock Is Worth a Wager

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...

Gambling on Biotechs—and Pfizer | Barron’s

To the Editor: Pfizer has a lot of good and bad points, as mentioned in your cover story “Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.” (Feb. 3). But the hardest one to deal with for all bio...

Everything GE CEO Larry Culp Had for Investors in the Annual Report

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...

Robinhood accidentally sold short on a meme stock and lost $57 million

Robinhood Markets Inc. accidentally sold short on a small stock as it went on a meme-like ride in December, costing the trading app more than the stock’s current market capitalization, executives disc...

15 dividend stocks whose 5% to 10% yields appear safe in 2023 and 2024 by this analysis

Corrected dividend stock screen table, because Hanesbrands had eliminated its dividend on Feb. 2. See note above table. If you are investing in dividend stocks, the last thing you want to see is a com...

Democrats’ Price Controls Undermine Biden’s Cancer Moonshot

WASHINGTON, DC – MARCH 01: U.S. President Joe Biden delivers the State of the Union address during a … [+] joint session of Congress in the U.S. Capitol’s House Chamber March 01, 202...

Enphase stock rallies 8% after Q4 earnings blow past expectations, guidance

Enphase Energy Inc. shares jumped more than 8% in the extended session Tuesday after the maker of inverters for solar-power systems reported fourth-quarter earnings that topped Wall Street views and u...

Top 3 Healthcare Stocks for February 2023

Here are 3 companies under heavy accumulation. Regeneron Pharmaceuticals, Inc. (REGN) Analysis First is biotech firm Regeneron Pharmaceuticals (REGN). The healthcare stock is up 8% in 2023. Healthy in...

40%, 5x, And The End of Free Money

The reality of technology serving the business has always been the case, but we have lived through a period of distortion that did not enhance the alignment of IT professionals with the businesses the...

I’m Worried About Healthcare Costs During Retirement. What Do I Need to Know?

costs of healthcare in retirement Healthcare is one of the biggest costs you will face in retirement. In fact, by many estimates, it’s the single biggest cost for retirees. A representative study by F...

Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy.

Pfizer probably did more than any other company to help the world normalize from the pandemic, and it reaped a financial windfall from its twin Covid-19 franchise—the top-selling vaccine and the leadi...

Eli Lilly and Novo Stock Sold Off. Don’t Blame Their Diet Drugs.

Stock in Eli Lilly and Novo Nordisk outperformed last year, largely because of remarkable demand for new drugs that drive weight loss in patients afflicted with diabetes and obesity. Both stocks were ...

There’s still too much risk in stock and bond markets. Earn this easy 4.5% return while you wait for stability, says trader who hit 2 big calls in 2022.

Ahead of major tech earnings later, Meta results are lighting up the Nasdaq Composite COMP, +2.97% for Thursday. The S&P 500 SPX, +1.40% is also up as investors take a glass-half full view of the ...

Meta, Merck, Apple, Alphabet, Amazon, and More Stock Market Movers

We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...

Top 5 blockchain projects in the healthcare sector to follow in 2023 – Cryptopolitan

The healthcare industry has become one of the most gigantic and important sectors, with a global market size of more than $12 trillion (Source: Cross River Therapy). However, there are multiple issues...

Pfizer CEO: Covid Infections Will Rise. So Will Paxlovid and Vaccine Sales.

Pfizer executives say Wall Street analysts haven’t understood just how powerful a hit the company’s Covid-19 products will take this year. That’s the explanation the company’s chief financial officer,...

Blockchain Technology in Healthcare Market Report 2023: Viability for Secure Data Storage and Exchange Boosts Adoption – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Blockchain Technology in Healthcare Market: Distribution by Type of Blockchain, Type of End-User, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2...

How The Industry Designed To Keep Us Well Is Also Making Our Planet – And Our Bodies – Sick

Healthcare systems undertake a fundamental and challenging mission: keeping us healthy. But true health and wellbeing extends beyond hospital walls and examination rooms. Our bodies and minds, after a...

GE HealthCare stock rises after reporting first results after GE spinoff, with revenue rising 8% but profit slipping

Shares of GE HealthCare GEHC, rose 1.3% in premarket trading Monday, reversing an earlier loss, after the medical technology and pharmaceutical diagnostics company reported its first results as a publ...

Tesla, GM, Lucid, Alibaba, and More Stock Market Movers

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...

I’m Worried About My Retirement Healthcare Costs. What Can I Do to Prep For it Now?

SmartAsset: Healthcare Costs in Retirement Retirement is often considered a great time to travel and do things you’ve been planning for years. You save and invest for multiple decades before deciding ...

Blackstone Stock Is a Good Investment, Even in a Downbeat Economy

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...

China’s Big Comeback Is Just Getting Started. How to Play It.

Talk about a comeback. As China abandons policies that stifled economic growth for the past three years, investors have sent the country’s stocks soaring—up more than 50% since October. The rally migh...

What investors need to know about Pfizer’s latest downgrade

Pfizer’s PFE, -0.92% early-stage pipeline, though promising, is still too premature to make up for the looming loss of billions of dollars from the company’s COVID-19 franchise, which includes the vac...

Microsoft, Texas Instruments, Tesla, Intuitive Surgical, and More Market Movers

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...

Amazon Launches $5 A Month Prescription Drug Scheme As It Leaps Further Into Healthcare

Topline Amazon on Tuesday announced a new prescription drug program giving subscribers as many medications as they need for a flat fee, the online retailer’s latest salvo in its bid to lure customers ...

3M, Lyft, Verizon, Lululemon, and More Stock Market Movers

We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...

J&J Reports Earnings Tuesday. What to Expect.

Johnson & Johnson CEO Joaquin Duato’s warning earlier this month that the outlook for 2023 remains uncertain is tempering investor expectations ahead of the company’s earnings reports on Tuesday. ...